{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T11:31:53Z","timestamp":1793705513059,"version":"4.5.1"},"reference-count":105,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,1]]},"abstract":"<jats:p>A significant number of advances have been made in the last 5 years with respect to the identification, diagnosis, assessment, and management of infants with prenatal opioid exposure and neonatal opioid withdrawal syndrome (NOWS) from birth to early childhood. The primary objective of this review is to summarize major advances that will inform the clinical management of opioid-exposed newborns and provide an overview of NOWS care to promote the implementation of best practices. First, advances with respect to standardizing the clinical diagnosis of NOWS will be reviewed. Second, the most commonly used assessment strategies are discussed, with a focus on presenting new quality improvement and clinical trial data surrounding the use of the new function-based assessment Eat, Sleep, and Console approach. Third, both nonpharmacologic and pharmacologic treatment modalities are reviewed, highlighting clinical trials that have compared the use of higher calorie and low lactose formula, vibrating crib mattresses, morphine compared with methadone, buprenorphine compared with morphine or methadone, the use of ondansetron as a medication to prevent the need for NOWS opioid pharmacologic treatment, and the introduction of symptom-triggered dosing compared with scheduled dosing. Fourth, maternal, infant, environmental, and genetic factors that have been found to be associated with NOWS severity are highlighted. Finally, emerging recommendations on postdelivery hospitalization follow-up and developmental surveillance are presented, along with highlighting ongoing and needed areas of research to promote infant and family well-being for families impacted by opioid use.<\/jats:p>","DOI":"10.1542\/peds.2023-062871","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T03:18:46Z","timestamp":1704424726000},"source":"Crossref","is-referenced-by-count":50,"title":["Advances in the Care of Infants With Prenatal Opioid Exposure and Neonatal Opioid Withdrawal Syndrome"],"prefix":"10.1542","volume":"153","author":[{"given":"Margarida","family":"Mascarenhas","sequence":"first","affiliation":[{"name":"aDivisions of General Academic Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisha M.","family":"Wachman","sequence":"additional","affiliation":[{"name":"bDepartment of Pediatrics, Boston Medical Center, and Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iyra","family":"Chandra","sequence":"additional","affiliation":[{"name":"cDana Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Xue","sequence":"additional","affiliation":[{"name":"dDepartment of Family Medicine, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leela","family":"Sarathy","sequence":"additional","affiliation":[{"name":"eNewborn Medicine, MassGeneral for Children, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davida M.","family":"Schiff","sequence":"additional","affiliation":[{"name":"aDivisions of General Academic Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"issue":"2","key":"2024020102571257700_B1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2020.24991","article-title":"Neonatal abstinence syndrome and maternal opioid-related diagnoses in the United States, 2010\u20132017","volume":"325","author":"Hirai","year":"2021","journal-title":"JAMA"},{"key":"2024020102571257700_B2","article-title":"Health Care Cost and Utilization Project (HCUP) fast stats","author":"Agency for Healthcare Research and Quality"},{"issue":"2","key":"2024020102571257700_B3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jamapediatrics.2019.4791","article-title":"Neonatal abstinence syndrome incidence and health care costs in the United States, 2016","volume":"174","author":"Strahan","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"3","key":"2024020102571257700_B4","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/AOG.0000000000003907","article-title":"Polysubstance use among pregnant women with opioid use disorder in the United States, 2007\u20132016","volume":"136","author":"Jarlenski","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2024020102571257700_B5","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s10995-023-03592-w","article-title":"Systematic review: polysubstance prevalence estimates reported during pregnancy, United States, 2009\u20132020","volume":"27","author":"Tran","year":"2023","journal-title":"Matern Child Health J"},{"key":"2024020102571257700_B6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.drugalcdep.2018.07.024","article-title":"Impact of psychiatric medication co-exposure on neonatal abstinence syndrome severity","volume":"192","author":"Wachman","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"2024020102571257700_B7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/AOG.0000000000003231","article-title":"Medication-assisted treatment use among pregnant women with opioid use disorder","volume":"133","author":"Krans","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2024020102571257700_B8","doi-asserted-by":"crossref","first-page":"e2020029074","DOI":"10.1542\/peds.2020-029074","article-title":"Neonatal opioid withdrawal syndrome","volume":"146","author":"Patrick","year":"2020","journal-title":"Pediatrics"},{"issue":"2","key":"2024020102571257700_B9","doi-asserted-by":"crossref","first-page":"e547","DOI":"10.1542\/peds.2013-3524","article-title":"Neonatal abstinence syndrome","volume":"134","author":"Kocherlakota","year":"2014","journal-title":"Pediatrics"},{"key":"2024020102571257700_B10","article-title":"ACOG Committee opinion no. 711: opioid use and opioid use disorder in pregnancy","author":"Committee on Obstetric Practice American Society of Addiction Medicine"},{"issue":"11","key":"2024020102571257700_B11","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1542\/neo.23-10-e788","article-title":"Equity in policies regarding urine drug testing in infants","volume":"23","author":"Murosko","year":"2022","journal-title":"NeoReviews"},{"issue":"6","key":"2024020102571257700_B12","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.acap.2023.01.012","article-title":"Disparities in maternal-infant drug testing, social work assessment, and custody at 5 hospitals","volume":"23","author":"Cohen","year":"2023","journal-title":"Acad Pediatr"},{"key":"2024020102571257700_B13","author":"United States Supreme Court. Ferguson v. Charleston, 532 U.S. 67. 2001"},{"key":"2024020102571257700_B14","article-title":"ASAM public policy: substance useand substance use disorder among pregnant and postpartum people","author":"American Society of Addiction Medicine"},{"key":"2024020102571257700_B15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jpeds.2021.12.021","article-title":"Standardizing the clinical definition of opioid withdrawal in the neonate","volume":"243","author":"Jilani","year":"2022","journal-title":"J Pediatr"},{"issue":"11","key":"2024020102571257700_B16","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/MLR.0000000000000805","article-title":"Trends in opioid-related inpatient stays shifted after the us transitioned to ICD-10-CM diagnosis coding in 2015","volume":"55","author":"Heslin","year":"2017","journal-title":"Med Care"},{"issue":"3","key":"2024020102571257700_B17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41372-022-01518-y","article-title":"Accuracy of diagnostic codes for prenatal opioid exposure and neonatal opioid withdrawal syndrome","volume":"43","author":"Kuzniewicz","year":"2023","journal-title":"J Perinatol"},{"key":"2024020102571257700_B18","article-title":"Neonatal abstinence syndrome (NAS) standardized surveillance case definition position statement","author":"Council of State and Territorial Epidemiologists (CSTE)"},{"issue":"3","key":"2024020102571257700_B19","doi-asserted-by":"crossref","first-page":"e20200567","DOI":"10.1542\/peds.2020-0567","article-title":"Diagnosis codes and case definitions for neonatal abstinence syndrome","volume":"146","author":"Elmore","year":"2020","journal-title":"Pediatrics"},{"key":"2024020102571257700_B20","doi-asserted-by":"crossref","first-page":"108765","DOI":"10.1016\/j.jsat.2022.108765","article-title":"\u201cYou have to take this medication, but then you get punished for taking it:\u201d lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period","volume":"139","author":"Schiff","year":"2022","journal-title":"J Subst Abuse Treat"},{"key":"2024020102571257700_B21","doi-asserted-by":"crossref","first-page":"107652","DOI":"10.1016\/j.drugalcdep.2019.107652","article-title":"Treatment for substance use disorders in pregnant women: motivators and barriers","volume":"205","author":"Frazer","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"2024020102571257700_B22","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1097\/ADM.0000000000000624","article-title":"The parental experience of newborns with neonatal abstinence syndrome across inpatient care settings: a qualitative study","volume":"14","author":"Buczkowski","year":"2020","journal-title":"J Addict Med"},{"issue":"6","key":"2024020102571257700_B23","doi-asserted-by":"crossref","first-page":"2022057529","DOI":"10.1542\/peds.2022-057529","article-title":"Recommended terminology for substance use disorders in the care of children, adolescents, young adults, and families","volume":"149","author":"Alinsky","year":"2022","journal-title":"Pediatrics"},{"key":"2024020102571257700_B24","article-title":"SPEAK UP Program","author":"Institute for Perinatal Quality Improvement"},{"issue":"5","key":"2024020102571257700_B25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1891\/0730-0832.35.5.327","article-title":"Adding to our practice toolkit: using the ACTS script to address stigmatizing peer behaviors in the context of maternal substance use","volume":"35","author":"Marcellus","year":"2016","journal-title":"Neonatal Netw"},{"key":"2024020102571257700_B26","article-title":"TIP 57: trauma-informed care in behavioral health services","author":"Substance Abuse Mental Health Services Administration"},{"issue":"4","key":"2024020102571257700_B27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jamapediatrics.2017.5195","article-title":"Association of rooming-in with outcomes for neonatal abstinence syndrome: a systematic review and meta-analysis","volume":"172","author":"MacMillan","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"10","key":"2024020102571257700_B28","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1080\/14767058.2017.1414180","article-title":"Nonpharmacological management of neonatal abstinence syndrome: a review of the literature","volume":"32","author":"Ryan","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"8","key":"2024020102571257700_B29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1055\/s-0040-1719182","article-title":"Rooming-in for infants at risk for neonatal abstinence syndrome: outcomes 5 years following its introduction as the standard of care at one hospital","volume":"39","author":"Newman","year":"2022","journal-title":"Am J Perinatol"},{"issue":"3","key":"2024020102571257700_B30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1542\/hpeds.2022-006882","article-title":"Admission and care practices in United States well newborn nurseries","volume":"13","author":"Joshi","year":"2023","journal-title":"Hosp Pediatr"},{"key":"2024020102571257700_B31","first-page":"100027","article-title":"Pilot study comparing adverse cardiorespiratory events among pharmacologically and nonpharmacologically treated infants undergoing monitoring for neonatal abstinence syndrome","volume":"3","author":"Davala","year":"2020","journal-title":"J Pediatr X"},{"issue":"5","key":"2024020102571257700_B32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/ADM.0000000000000607","article-title":"Avoiding NICU transfers for newborns with neonatal opioid withdrawal syndrome (NOWS): a quality improvement initiative to manage NOWS on the mother\u2013baby unit","volume":"14","author":"Spence","year":"2020","journal-title":"J Addict Med"},{"issue":"8","key":"2024020102571257700_B33","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/jamapediatrics.2018.1307","article-title":"Comparison of safety and efficacy of methadone vs morphine for treatment of neonatal abstinence syndrome: a randomized clinical trial","volume":"172","author":"Davis","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"4","key":"2024020102571257700_B34","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.nwh.2023.02.004","article-title":"Effects on Neonatal abstinence syndrome of parental caregivers\u2019 ability to leave the postpartum unit during the COVID-19 pandemic","volume":"27","author":"Cooney","year":"2023","journal-title":"Nurs Womens Health"},{"key":"2024020102571257700_B35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpeds.2022.02.001","article-title":"Impact of coronavirus disease 2019 on hospital care for neonatal opioid withdrawal syndrome","volume":"245","author":"MacMillan","year":"2022","journal-title":"J Pediatr"},{"issue":"1-2","key":"2024020102571257700_B36","first-page":"141","article-title":"Neonatal abstinence syndrome: assessment and management","volume":"2","author":"Finnegan","year":"1975","journal-title":"Addict Dis"},{"issue":"4","key":"2024020102571257700_B37","doi-asserted-by":"crossref","first-page":"e202275","DOI":"10.1001\/jamanetworkopen.2020.2275","article-title":"Association of a simplified Finnegan Neonatal Abstinence Scoring Tool with the need for pharmacologic treatment for neonatal abstinence syndrome","volume":"3","author":"Devlin","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"7","key":"2024020102571257700_B38","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/s41372-020-0606-4","article-title":"Development of an abbreviated symptom score for the neonatal abstinence syndrome","volume":"40","author":"Chervoneva","year":"2020","journal-title":"J Perinatol"},{"issue":"1","key":"2024020102571257700_B39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/hpeds.2017-0128","article-title":"A novel approach to assessing infants with neonatal abstinence syndrome","volume":"8","author":"Grossman","year":"2018","journal-title":"Hosp Pediatr"},{"issue":"10","key":"2024020102571257700_B40","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/s41372-020-0733-y","article-title":"A quality improvement initiative to implement the eat, sleep, console neonatal opioid withdrawal syndrome care tool in Massachusetts\u2019 PNQIN collaborative","volume":"40","author":"Wachman","year":"2020","journal-title":"J Perinatol"},{"issue":"9","key":"2024020102571257700_B41","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1542\/hpeds.2020-0032","article-title":"The Colorado Hospitals Substance Exposed Newborn Quality Improvement Collaborative: standardization of care for opioid-exposed newborns shortens length of stay and reduces number of infants requiring opiate therapy","volume":"10","author":"Hwang","year":"2020","journal-title":"Hosp Pediatr"},{"issue":"25","key":"2024020102571257700_B42","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa2214470","article-title":"Eat, Sleep, Console approach or usual care for neonatal opioid withdrawal","volume":"388","author":"Young","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"2024020102571257700_B43","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1186\/s13063-022-06445-z","article-title":"Eating, sleeping, consoling for neonatal opioid withdrawal (ESC-NOW): a function-based assessment and management approach study protocol for a multicenter, stepped-wedge randomized controlled trial","volume":"23","author":"Young","year":"2022","journal-title":"Trials"},{"key":"2024020102571257700_B44","doi-asserted-by":"crossref","first-page":"107032","DOI":"10.1016\/j.ntt.2021.107032","article-title":"Reconceptualizing nonpharmacologic approaches to neonatal abstinence syndrome (NAS) and neonatal opioid withdrawal syndrome (NOWS): a theoretical and evidence-based approach. Part II: the clinical application of nonpharmacologic care for NAS\/NOWS","volume":"88","author":"Velez","year":"2021","journal-title":"Neurotoxicol Teratol"},{"issue":"7","key":"2024020102571257700_B45","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jamapediatrics.2023.1077","article-title":"Efficacy of a vibrating crib mattress to reduce pharmacologic treatment in opioid-exposed newborns: a randomized clinical trial","volume":"177","author":"Bloch-Salisbury","year":"2023","journal-title":"JAMA Pediatr"},{"issue":"12","key":"2024020102571257700_B46","first-page":"CD013217","article-title":"Nonpharmacological care for opioid withdrawal in newborns","volume":"12","author":"Pahl","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2024020102571257700_B47","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s41372-019-0374-1","article-title":"Maternal breast milk feeding and length of treatment in infants with neonatal abstinence syndrome","volume":"39","author":"Favara","year":"2019","journal-title":"J Perinatol"},{"key":"2024020102571257700_B48","doi-asserted-by":"crossref","unstructured":"Harris M, Schiff DM, Saia K, Muftu S, et al. Academy of breastfeeding medicine clinical protocol #21: Breastfeeding in the setting of substance use and substance use disorder. Rev Breastfeed Med.\n          2023;18(10):715\u2013733","DOI":"10.1089\/bfm.2023.29256.abm"},{"issue":"1","key":"2024020102571257700_B49","doi-asserted-by":"crossref","first-page":"e2022057988","DOI":"10.1542\/peds.2022-057988","article-title":"Policy statement: breastfeeding and theuse of human milk","volume":"150","author":"Meek","year":"2022","journal-title":"Pediatrics"},{"key":"2024020102571257700_B50","first-page":"X211035258","article-title":"Effect of low lactose formula on the short-term outcomes of neonatal abstinence syndrome: a systematic review","volume":"8","author":"Alsaleem","year":"2021","journal-title":"Glob Pediatr Health"},{"issue":"3","key":"2024020102571257700_B51","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41372-020-00797-7","article-title":"Lactose-free infant formula does not change outcomes of neonatal abstinence syndrome (NAS): a randomized clinical trial","volume":"41","author":"Pandey","year":"2021","journal-title":"J Perinatol"},{"issue":"14","key":"2024020102571257700_B52","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1055\/s-0040-1713754","article-title":"Breastfeeding and formula selection in neonatal abstinence syndrome","volume":"38","author":"Lembeck","year":"2021","journal-title":"Am J Perinatol"},{"issue":"4","key":"2024020102571257700_B53","doi-asserted-by":"crossref","first-page":"e20190914","DOI":"10.1542\/peds.2019-0914","article-title":"Orchestrated testing of formula type to reduce length of stay in neonatal abstinence syndrome","volume":"146","author":"Kaplan","year":"2020","journal-title":"Pediatrics"},{"issue":"11","key":"2024020102571257700_B54","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1055\/s-0039-1692684","article-title":"Effects of partially hydrolyzed formula on severity and outcomes of neonatal abstinence syndrome","volume":"37","author":"Alsaleem","year":"2020","journal-title":"Am J Perinatol"},{"issue":"1","key":"2024020102571257700_B55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1542\/hpeds.2017-0114","article-title":"Randomized clinical trial of standard- versus high-calorie formula for methadone-exposed infants: a feasibility study","volume":"8","author":"Bogen","year":"2018","journal-title":"Hosp Pediatr"},{"issue":"10","key":"2024020102571257700_B56","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1542\/hpeds.2021-006137","article-title":"Early weight loss percentile curves and feeding practices in opioid-exposed infants","volume":"12","author":"Cheng","year":"2022","journal-title":"Hosp Pediatr"},{"key":"2024020102571257700_B57","doi-asserted-by":"crossref","first-page":"805763","DOI":"10.3389\/fped.2021.805763","article-title":"Aberrant feeding and growth in neonates with prenatal opioid exposure: evidence of neuromodulation and behavioral changes","volume":"9","author":"Yen","year":"2022","journal-title":"Front Pediatr"},{"issue":"1","key":"2024020102571257700_B58","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s12887-022-03401-3","article-title":"Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study","volume":"22","author":"Sutter","year":"2022","journal-title":"BMC Pediatr"},{"issue":"24","key":"2024020102571257700_B59","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1056\/NEJMoa1614835","article-title":"Buprenorphine for the treatment of the neonatal abstinence syndrome","volume":"376","author":"Kraft","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"2024020102571257700_B60","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-0037-1608634","article-title":"Comparison of neonatal abstinence syndrome treatment with sublingual buprenorphine versus conventional opioids","volume":"35","author":"Hall","year":"2018","journal-title":"Am J Perinatol"},{"issue":"7","key":"2024020102571257700_B61","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/s41372-020-0685-2","article-title":"Clonidine versus phenobarbital as adjunctive therapy for neonatal abstinence syndrome","volume":"40","author":"Brusseau","year":"2020","journal-title":"J Perinatol"},{"issue":"3","key":"2024020102571257700_B62","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41372-022-01487-2","article-title":"Ondansetron to reduce neonatal opioid withdrawal severity a randomized clinical trial","volume":"43","author":"Peltz","year":"2023","journal-title":"J Perinatol"},{"issue":"4","key":"2024020102571257700_B63","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1542\/peds.2015-1141","article-title":"Implementation of a neonatal abstinence syndrome weaning protocol: a multicenter cohort study","volume":"136","author":"Hall","year":"2015","journal-title":"Pediatrics"},{"key":"2024020102571257700_B64","article-title":"Trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS)","author":"ClinicalTrials.gov"},{"issue":"8","key":"2024020102571257700_B65","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1542\/hpeds.2019-0144","article-title":"A quality improvement initiative to improve the care of infants born exposed to opioids by implementing the eat, sleep, console assessment tool","volume":"9","author":"Achilles","year":"2019","journal-title":"Hosp Pediatr"},{"issue":"8","key":"2024020102571257700_B66","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1542\/hpeds.2019-0083","article-title":"Improving care for infants with neonatal abstinence syndrome: a multicenter, community hospital-based study","volume":"9","author":"Parlaman","year":"2019","journal-title":"Hosp Pediatr"},{"issue":"5","key":"2024020102571257700_B67","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1542\/hpeds.2021-006301","article-title":"Neonatal opioid withdrawal syndrome: a comparison of as-needed pharmacotherapy","volume":"12","author":"Morrison","year":"2022","journal-title":"Hosp Pediatr"},{"key":"2024020102571257700_B68","article-title":"The OPTimize NOW Study","author":"NIH Heal Initiative"},{"issue":"22","key":"2024020102571257700_B69","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1056\/NEJMoa2203318","article-title":"Buprenorphine versus methadone for opioid use disorder in pregnancy","volume":"387","author":"Suarez","year":"2022","journal-title":"N Engl J Med"},{"issue":"22","key":"2024020102571257700_B70","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMe2212967","article-title":"Neonatal outcomes after use of buprenorphine during pregnancy","volume":"387","author":"Krans","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"2024020102571257700_B71","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/aje\/kwab249","article-title":"Trajectories of prescription opioid utilization during pregnancy among prepregnancy chronic users and risk of neonatal opioid withdrawal syndrome","volume":"191","author":"Straub","year":"2022","journal-title":"Am J Epidemiol"},{"issue":"6","key":"2024020102571257700_B72","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41372-021-00969-z","article-title":"Predictors of pharmacologic therapy for neonatal opioid withdrawal syndrome: a retrospective analysis of a statewide database","volume":"41","author":"Singh","year":"2021","journal-title":"J Perinatol"},{"issue":"6","key":"2024020102571257700_B73","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1007\/s10995-022-03521-3","article-title":"The influence of mediators on the relationship between antenatal opioid agonist exposure and the severity of neonatal opioid withdrawal syndrome","volume":"27","author":"Devlin","year":"2023","journal-title":"Matern Child Health J"},{"issue":"4","key":"2024020102571257700_B74","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0040-1716490","article-title":"Hospital outcomes of infants with neonatal opioid withdrawal syndrome at a tertiary care hospital with high rates of concurrent nonopioid (polysubstance) exposure","volume":"39","author":"Morris","year":"2022","journal-title":"Am J Perinatol"},{"issue":"4","key":"2024020102571257700_B75","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41390-021-01756-4","article-title":"Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors","volume":"91","author":"Bakhireva","year":"2022","journal-title":"Pediatr Res"},{"issue":"3","key":"2024020102571257700_B76","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/ADM.0000000000000484","article-title":"Impact of in-utero exposure to selective serotonin reuptake inhibitors and opioids on neonatal opioid withdrawal syndrome","volume":"13","author":"Bhatt-Mehta","year":"2019","journal-title":"J Addict Med"},{"issue":"8","key":"2024020102571257700_B77","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1542\/hpeds.2018-0227","article-title":"Increased severity of neonatal abstinence syndrome associated with concomitant antenatal opioid and benzodiazepine exposure","volume":"9","author":"Sanlorenzo","year":"2019","journal-title":"Hosp Pediatr"},{"issue":"5","key":"2024020102571257700_B78","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/s41390-022-02243-0","article-title":"Polygenic risk scores and the need for pharmacotherapy in neonatal abstinence syndrome","volume":"93","author":"Bibi","year":"2023","journal-title":"Pediatr Res"},{"issue":"3","key":"2024020102571257700_B79","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ygeno.2021.03.006","article-title":"Placental DNA methylation profiles in opioid-exposed pregnancies and associations with the neonatal opioid withdrawal syndrome","volume":"113","author":"Radhakrishna","year":"2021","journal-title":"Genomics"},{"issue":"5","key":"2024020102571257700_B80","first-page":"1368","article-title":"Prenatal opioid-exposed infant extracellular miRNA signature obtained at birth predicts severity of neonatal opioid withdrawal syndrome","volume":"93","author":"Mahnke","year":"2022","journal-title":"Sci Rep"},{"issue":"5","key":"2024020102571257700_B81","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3390\/biomedicines10051150","article-title":"Effect of prenatal opioid exposure on the human placental methylome","volume":"10","author":"Borrelli","year":"2022","journal-title":"Biomedicines"},{"issue":"8","key":"2024020102571257700_B82","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1542\/hpeds.2019-0088","article-title":"Improving the discharge process for opioid-exposed neonates","volume":"9","author":"Crook","year":"2019","journal-title":"Hosp Pediatr"},{"issue":"2","key":"2024020102571257700_B83","doi-asserted-by":"crossref","first-page":"e20191275","DOI":"10.1542\/peds.2019-1275","article-title":"Well-child care adherence after intrauterine opioid exposure","volume":"145","author":"Goyal","year":"2020","journal-title":"Pediatrics"},{"issue":"6","key":"2024020102571257700_B84","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/DBP.0000000000000679","article-title":"Early intervention referral and enrollment among infants with neonatal abstinence syndrome","volume":"40","author":"Peacock-Chambers","year":"2019","journal-title":"J Dev Behav Pediatr"},{"key":"2024020102571257700_B85","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jpeds.2018.08.032","article-title":"A longitudinal health care use profile of children with a history of neonatal abstinence syndrome","volume":"204","author":"Liu","year":"2019","journal-title":"J Pediatr"},{"key":"2024020102571257700_B86","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jpeds.2021.01.067","article-title":"Longitudinal health care utilization of Medicaid-insured children with a history of neonatal abstinence syndrome","volume":"233","author":"Corr","year":"2021","journal-title":"J Pediatr"},{"key":"2024020102571257700_B87","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jpeds.2020.03.052","article-title":"Subclinical and overt newborn opioid exposure: prevalence and first-year health care utilization","volume":"222","author":"Percy","year":"2020","journal-title":"J Pediatr"},{"issue":"7","key":"2024020102571257700_B88","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jamapediatrics.2020.6364","article-title":"Infant mortality associated with prenatal opioid exposure","volume":"175","author":"Leyenaar","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"7","key":"2024020102571257700_B89","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/jamapediatrics.2023.1047","article-title":"Maternal opioid use disorder and the risk of postneonatal infant mortality","volume":"177","author":"Grossarth","year":"2023","journal-title":"JAMA Pediatr"},{"issue":"6","key":"2024020102571257700_B90","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1038\/s41390-022-02279-2","article-title":"Outcomes of babies with opioid exposure (OBOE): protocol of a prospective longitudinal cohort study","volume":"93","author":"Bann","year":"2023","journal-title":"Pediatr Res"},{"key":"2024020102571257700_B91","article-title":"HEALthy Brain and Child Development Study (HBCD)","author":"NIH HEAL Initiative"},{"issue":"3","key":"2024020102571257700_B92","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.acap.2019.11.005","article-title":"Neurodevelopmental outcomes of children born to opioid-dependent mothers: a systematic review and meta-analysis","volume":"20","author":"Lee","year":"2020","journal-title":"Acad Pediatr"},{"issue":"7","key":"2024020102571257700_B93","doi-asserted-by":"crossref","first-page":"e197025","DOI":"10.1001\/jamanetworkopen.2019.7025","article-title":"Cognitive and Motor outcomes of children with prenatal opioid exposure: a systematic review and meta-analysis","volume":"2","author":"Yeoh","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"2","key":"2024020102571257700_B94","first-page":"106","article-title":"Prenatal opioid exposure and ADHD childhood symptoms: a meta-analysis","volume":"8","author":"Schwartz","year":"2021","journal-title":"Children (Basel)"},{"key":"2024020102571257700_B95","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jpeds.2019.12.018","article-title":"Neurodevelopmental outcomes of neonates randomized to morphine or methadone for treatment of neonatal abstinence syndrome","volume":"219","author":"Czynski","year":"2020","journal-title":"J Pediatr"},{"key":"2024020102571257700_B96","article-title":"ACT NOW longitudinal study: Outcomes of Babies with Opioid Exposure Study (OBOE)","author":"ClinicalTrials.gov"},{"issue":"1","key":"2024020102571257700_B97","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clp.2022.10.007","article-title":"Neonatal opioid withdrawal syndrome: an update on developmental outcomes","volume":"50","author":"Benninger","year":"2023","journal-title":"Clin Perinatol"},{"key":"2024020102571257700_B98","author":"Individuals With Disabilities Education Act, 20 U.S.C. & Part C. 2004"},{"key":"2024020102571257700_B99","article-title":"34 CFR Part 303, 303.21(b), 303.5","author":"National Archives"},{"key":"2024020102571257700_B100","article-title":"HCV guidance: recommendations for testing, managing and treating hepatitis C","author":"American Association for the Study of Liver Diseases; Infectious Diseases Society of America"},{"key":"2024020102571257700_B101","first-page":"1","author":"Panagiotakopoulos L, Sandul AL, et al.","year":"2023"},{"key":"2024020102571257700_B102","doi-asserted-by":"crossref","first-page":"104601","DOI":"10.1016\/j.neubiorev.2022.104601","article-title":"Ophthalmic outcomes in children exposed to opioid maintenance treatment in utero: A systematic review and meta-analysis","volume":"136","author":"Hemmati","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"2024020102571257700_B103","article-title":"21st Century Cures Act","author":"US Food and DrugAdministration"},{"issue":"1","key":"2024020102571257700_B104","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13063-020-4183-9","article-title":"Outcome reporting in neonates experiencing withdrawal following opioid exposure in pregnancy: a systematic review","volume":"21","author":"Shan","year":"2020","journal-title":"Trials"},{"issue":"1","key":"2024020102571257700_B105","doi-asserted-by":"crossref","first-page":"e20200018","DOI":"10.1542\/peds.2020-0018","article-title":"A core outcome set for neonatal opioid withdrawal syndrome","volume":"146","author":"Kelly","year":"2020","journal-title":"Pediatrics"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2023-062871\/1593395\/peds.2023-062871.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2023-062871\/1593395\/peds.2023-062871.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T21:58:08Z","timestamp":1706738288000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/153\/2\/e2023062871\/196385\/Advances-in-the-Care-of-Infants-With-Prenatal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":105,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,5]]},"published-print":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2023-062871","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,1]]},"article-number":"e2023062871"}}